GBS is a biosensor diagnostic technology company. Co.'s products are: Biosensor Platform Technology, which the Saliva Glucose Biosensor (SGB) is based is a modified Organic Thin Film Transistor; Saliva Glucose Test, which consists of the SGB, which is a single use disposable saliva biosensor, and software app on a smart device or a dedicated reader that interfaces the SGB with its digital information system; and SGB, which has the sensitivity of the glucose biosensor that enables it to detect glucose in saliva at concentrations and exhibits linear glucose sensing characteristics at these concentrations, sensing glucose at levels 100 times lower than in blood. We show 10 historical shares outstanding datapoints in our GBS shares outstanding history coverage, used to compute GBS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GBS market cap history over the course of time is important for investors
interested in comparing GBS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GBS versus a peer is one thing; comparing
GBS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GBS can fluctuate over the course of history.
With this page we aim to empower investors researching GBS by allowing them to research the GBS market cap history. |
Free GBS Email Alerts:
Video: The Importance of Market Cap
